Amundi Has $649,000 Holdings in U.S. Physical Therapy, Inc. (NYSE:USPH)

Amundi boosted its stake in U.S. Physical Therapy, Inc. (NYSE:USPH) by 174.5% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,286 shares of the company’s stock after buying an additional 4,632 shares during the quarter. Amundi’s holdings in U.S. Physical Therapy were worth $649,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of USPH. Bahl & Gaynor Inc. boosted its stake in U.S. Physical Therapy by 135.4% in the 4th quarter. Bahl & Gaynor Inc. now owns 260,125 shares of the company’s stock valued at $23,076,000 after buying an additional 149,622 shares in the last quarter. State Street Corp boosted its stake in U.S. Physical Therapy by 17.5% in the 3rd quarter. State Street Corp now owns 667,868 shares of the company’s stock valued at $56,522,000 after buying an additional 99,244 shares in the last quarter. Copeland Capital Management LLC boosted its stake in U.S. Physical Therapy by 9.5% in the 4th quarter. Copeland Capital Management LLC now owns 839,356 shares of the company’s stock valued at $74,459,000 after buying an additional 72,715 shares in the last quarter. Raymond James Financial Inc. acquired a new stake in U.S. Physical Therapy in the 4th quarter valued at $6,240,000. Finally, Southernsun Asset Management LLC boosted its stake in U.S. Physical Therapy by 10.5% in the 3rd quarter. Southernsun Asset Management LLC now owns 547,111 shares of the company’s stock valued at $46,302,000 after buying an additional 52,062 shares in the last quarter.

Wall Street Analysts Forecast Growth

Several analysts recently commented on the company. Bank of America raised U.S. Physical Therapy from a “neutral” rating to a “buy” rating and boosted their price target for the company from $100.00 to $115.00 in a research note on Monday, December 16th. Citizens Jmp upgraded U.S. Physical Therapy to a “strong-buy” rating in a research report on Monday, December 16th. JMP Securities started coverage on U.S. Physical Therapy in a research report on Monday, December 16th. They issued an “outperform” rating and a $113.00 price objective for the company. JPMorgan Chase & Co. cut their price objective on U.S. Physical Therapy from $120.00 to $110.00 and set an “overweight” rating for the company in a research report on Wednesday. Finally, Barrington Research cut their price objective on U.S. Physical Therapy from $108.00 to $98.00 and set an “outperform” rating for the company in a research report on Friday, February 28th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $109.00.

Insider Buying and Selling at U.S. Physical Therapy

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,730 shares of the company’s stock in a transaction on Friday, March 7th. The shares were sold at an average price of $82.11, for a total transaction of $142,050.30. Following the completion of the sale, the chief operating officer now owns 7,168 shares in the company, valued at approximately $588,564.48. The trade was a 19.44 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 1.70% of the company’s stock.

U.S. Physical Therapy Stock Down 0.3 %

Shares of USPH opened at $75.95 on Thursday. The firm has a market capitalization of $1.15 billion, a price-to-earnings ratio of 80.80, a PEG ratio of 3.54 and a beta of 1.51. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.78 and a current ratio of 1.78. The business’s fifty day moving average price is $85.43 and its two-hundred day moving average price is $87.17. U.S. Physical Therapy, Inc. has a 52 week low of $74.76 and a 52 week high of $113.63.

U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings data on Wednesday, February 26th. The company reported $0.65 EPS for the quarter, missing analysts’ consensus estimates of $0.69 by ($0.04). The firm had revenue of $180.45 million during the quarter, compared to the consensus estimate of $173.10 million. U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. On average, analysts predict that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current year.

U.S. Physical Therapy Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 11th. Shareholders of record on Friday, March 14th will be given a dividend of $0.45 per share. This is a boost from U.S. Physical Therapy’s previous quarterly dividend of $0.44. The ex-dividend date of this dividend is Friday, March 14th. This represents a $1.80 annualized dividend and a dividend yield of 2.37%. U.S. Physical Therapy’s payout ratio is presently 97.83%.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.